Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Admelog Generic Name & Formulations
Legal Class
Rx
General Description
Insulin lispro 100 Units/mL; soln for SC inj or continuous subcutaneous insulin infusion pump, or IV inj; contains zinc, m-cresol.
How Supplied
Multi-dose vials (3mL, 10mL)—1; SoloStar prefilled pen (3mL)—5
Manufacturer
Generic Availability
NO
Admelog Indications
Indications
Type 1 diabetes mellitus in adults and children. Type 2 diabetes mellitus in adults.
Admelog Dosage and Administration
Adults and Children
<3yrs: not established. ≥3yrs: Individualize. For SC inj: give within 15mins before a meal or immediately after a meal; use with intermediate or long-acting insulin. Rotate inj sites (abdomen, thigh, upper arm, buttocks). For continuous SC infusion pump: administer into abdominal wall; do not dilute or mix Admelog; change Admelog in the reservoir at least every 7 days, change the infusion sets and insertion site at least every 3 days. For IV inj: dilute Admelog; give only under medical supervision; closely monitor blood glucose and potassium.
Admelog Contraindications
Contraindications
During episodes of hypoglycemia.
Admelog Boxed Warnings
Not Applicable
Admelog Warnings/Precautions
Warnings/Precautions
Instruct patients on proper administration of insulin, check insulin label before each injection, and management of hypoglycemia. Do not share pens between patients, or needles and syringes when using vials, even if the needle is changed. Do not inject into areas of lipodystrophy or localized cutaneous amyloidosis. Increased risk of hyperglycemia of hypoglycemia if changes in physical activity, meal patterns, concomitant medications, renal or hepatic function, insulin regimen, administration site, and if acute illness occurs: monitor glucose more frequently and may need to adjust dose. Monitor potassium levels in patients at risk for hypokalemia (eg, concomitant K+-lowering or K+-sensitive drugs). Discontinue if hypersensitivity reactions occur. Hyperglycemia and ketoacidosis due to insulin pump device malfunction: see full labeling. Renal or hepatic impairment. Pregnancy. Nursing mothers.
Admelog Pharmacokinetics
See Literature
Admelog Interactions
Interactions
Concomitant thiazolidinediones (TZDs) may cause fluid retention and heart failure; consider dose reduction or discontinue TZDs. Potentiated by oral antidiabetic agents, ACE inhibitors, ARBs, disopyramide, fibrates, fluoxetine, MAOIs, pentoxifylline, pramlintide, salicylates, somatostatin analogs (eg, octreotide), sulfonamide antibiotics. Antagonized by atypical antipsychotics, corticosteroids, isoniazid, niacin, danazol, diuretics, glucagon, phenothiazines, sympathomimetics, somatropin, thyroid hormones, oral contraceptives, estrogens, protease inhibitors. Variable effects with β-blockers, clonidine, lithium salts, alcohol, pentamidine. Concomitant β-blockers, clonidine, guanethidine, reserpine may blunt hypoglycemia. Do not mix with any other insulin.
Admelog Adverse Reactions
Adverse Reactions
Hypoglycemia, allergic reactions, inj site reactions, lipodystrophy, pruritus, rash, hypokalemia, weight gain, peripheral edema; hypersensitivity reactions.
Admelog Clinical Trials
See Literature
Admelog Note
Not Applicable
Admelog Patient Counseling
See Literature
